porcin
epidem
diarrhea
viru
pedv
caus
agent
porcin
epidem
diarrhea
ped
highli
contagi
enter
diseas
character
sever
wateri
diarrhea
vomit
dehydr
lead
enorm
econom
loss
swine
industri
worldwid
pedv
first
report
belgium
unit
kingdom
emerg
european
countri
follow
sever
year
pedv
infect
pig
age
caus
high
mortal
newborn
piglet
mortal
rate
nearli
howev
pedv
mainli
caus
slow
growth
adult
pig
decemb
newli
emerg
high
virul
strain
pedv
rapidli
spread
china
kill
piglet
mortal
rate
suckl
piglet
approach
pedv
identifi
member
genu
alphacoronaviru
within
famili
coronavirida
order
nidoviral
envelop
singlestrand
positivesens
rna
viru
genom
approxim
kb
length
compris
least
seven
open
read
frame
orf
encod
nonstructur
protein
structur
spike
envelop
e
membran
nucleocapsid
n
one
four
structur
protein
n
protein
associ
viral
replic
transcript
assembl
basic
intern
phosphoprotein
import
induc
cellmedi
immun
host
pig
produc
high
level
antibodi
n
protein
earli
stage
pedv
infect
antin
protein
igg
antibodi
first
detect
day
post
infect
pedv
n
protein
best
candid
antigen
earli
diagnosi
gene
highli
conserv
recent
decad
varieti
method
detect
pedv
develop
report
numer
studi
sinc
clinic
sign
histolog
chang
ped
diarrheal
diseas
transmiss
gastroenter
tge
similar
diagnos
without
molecular
method
immunoassay
convent
pedv
diagnost
method
base
laboratori
test
includ
viru
isol
convent
revers
transcriptionpolymeras
chain
reaction
rtpcr
realtim
rtpcr
indirect
fluoresc
antibodi
ifa
assay
enzymelink
immunosorb
assay
elisa
howev
convent
method
timeconsum
expens
exhibit
low
specif
sensit
requir
welltrain
technician
special
instrument
moreov
issu
falseposit
result
may
aris
crosscontamin
sampl
transport
delay
current
differ
type
elisa
includ
indirect
competit
block
elisa
wide
appli
detect
pedv
largescal
blood
fece
sampl
assay
base
use
pedvspecif
monoclon
polyclon
antibodi
requir
support
cost
exhibit
low
express
yield
high
level
instabl
antibodymedi
immun
detect
popular
approach
due
conveni
nanobodi
also
term
variabl
domain
heavychain
antibodi
vhh
surpris
discov
sera
camelid
llama
dromedari
camel
alpaca
vicuna
nanobodi
also
smallest
antibodi
complet
antigenbind
site
singledomain
natur
nanobodi
due
lack
light
chain
confer
mani
special
properti
observ
convent
antibodi
includ
high
affin
thermal
stabil
high
yield
microbi
product
system
moreov
molecular
weight
nanobodi
approxim
kda
associ
concav
epitop
nanobodi
might
better
adapt
access
hidden
target
cryptic
site
antibodi
base
uniqu
featur
nanobodi
hold
great
potenti
candid
divers
biomed
applic
diseas
diagnosi
therapeut
pedvspecif
nanobodi
yet
report
howev
motiv
use
phage
display
technolog
obtain
special
nanobodi
n
protein
pedv
select
nanobodi
appli
develop
block
elisa
rapid
lowcost
sensit
detect
pedv
serum
sampl
overal
detect
system
extrem
use
futur
pedv
diagnosi
inform
serum
sampl
use
studi
avail
materi
method
section
addit
file
male
bactrian
camel
immun
recombin
pedv
n
protein
describ
previou
studi
modif
peripher
blood
lymphocyt
pbl
isol
fresh
blood
describ
detail
addit
file
total
rna
isol
pbl
use
rnaiso
plu
takara
japan
accord
manufactur
instruct
rna
revers
transcrib
cdna
use
superscript
iii
firststrand
synthesi
system
thermo
fisher
usa
variabl
region
vhh
amplifi
nest
pcr
use
prime
star
hs
dna
polymeras
takara
japan
previous
describ
primer
first
pcr
product
contain
bp
fragment
amplifi
primer
sangon
biotech
china
addit
file
tabl
approxim
bp
vhh
fragment
pcramplifi
vhhfor
vhhrev
primer
contain
psti
noti
site
addit
file
tabl
first
purifi
product
use
templat
pcantab
phagemid
vector
ge
healthcar
life
scienc
usa
purifi
vhh
product
digest
use
psti
noti
restrict
enzym
new
england
biolab
neb
ligat
dna
ligas
new
england
biolab
neb
ligat
materi
electropor
electrocompet
e
coli
cell
transform
cell
cultur
lb
agar
plate
contain
vv
glucos
ampicillin
overnight
coloni
scrape
store
lb
contain
glycerol
size
divers
librari
evalu
calcul
number
coloni
insert
rate
pcr
amplif
gradient
dilut
posit
clone
sequenc
recombin
e
coli
contain
pcantab
plasmid
inocul
yt
medium
contain
vv
glucos
ampicillin
vigor
shake
rmin
optic
densiti
nm
bacteri
cultur
reach
approxim
helper
phage
ad
cell
incub
h
without
shake
cell
harvest
centrifug
min
cell
resuspend
grown
overnight
yt
medium
contain
ampicillin
kanamycin
cell
cultur
collect
centrifug
min
supernat
mix
pegnacl
phage
precipit
centrifug
min
h
incub
ice
final
phage
particl
resuspend
ml
phosphat
buffer
salin
pb
quantifi
phage
titrat
remain
phage
store
subsequ
experi
one
hundr
microlit
phage
particl
dissolv
pb
serial
dilut
tenfold
yt
medium
suspens
contain
cell
ad
cell
incub
halfhour
without
shake
transform
cell
cultur
lb
agar
plate
contain
vv
glucos
ampicillin
overnight
next
day
plate
contain
approxim
coloni
select
phage
quantifi
follow
formula
titer
valu
number
coloni
dilut
select
special
nanobodi
pedv
n
protein
three
consecut
round
biopan
perform
target
protein
plate
coat
pedv
n
protein
dilut
pb
overnight
pb
condit
use
control
next
day
pan
plate
block
wv
nonfat
dri
milk
pb
mpb
h
block
well
wash
four
time
pbst
pb
vv
resuspend
phage
particl
dilut
mpb
prepar
concentr
pfuml
incub
pan
plate
h
well
wash
pbst
ten
time
pb
five
time
special
phage
particl
elut
mm
triethylamin
sigma
usa
min
supernat
transfer
ml
tube
follow
ph
ad
neutral
solut
ml
aliquot
fresh
exponenti
grow
e
coli
cultur
infect
ml
aliquot
elut
phage
particl
halfhour
without
shake
follow
incub
ml
yt
medium
contain
vv
glucos
ampicillin
vigor
shake
rmin
bacteria
cultur
reach
approxim
helper
phage
ad
cell
rescu
enrich
special
phage
particl
three
consecut
round
biopan
procedur
describ
enrich
round
pan
assess
phage
titrat
elisa
coloni
pcr
total
differ
coloni
randomli
select
third
round
pan
cultur
plate
contain
lb
agar
vv
glucos
ampicillin
h
clone
cultur
transfer
ml
terrif
broth
tb
plate
incub
vigor
shake
speed
rmin
bacteri
cultur
reach
approxim
mm
iptg
ad
tb
induc
vhh
antibodi
express
cultur
incub
overnight
antibodi
extract
use
osmot
shock
protocol
identifi
periplasm
extract
elisa
peelisa
plate
coat
pedv
n
protein
dilut
pb
overnight
pb
condit
use
control
next
day
well
block
wv
mpb
h
extract
antibodi
dilut
mpb
ad
well
incub
h
afterward
rabbit
antietag
polyclon
antibodi
dilut
mpb
ad
well
incub
h
plate
wash
four
time
pbst
goat
antirabbit
monoclon
antibodi
conjug
hrp
dilut
mpb
transgen
biotech
china
ad
incub
h
anoth
wash
step
fresh
tmb
tmb
ml
citrat
buffer
ph
solut
ad
plate
incub
min
reaction
stop
addit
absorb
nm
read
microtit
plate
reader
biorad
usa
absorb
antigenco
well
least
threefold
greater
well
contain
pb
coloni
regard
posit
subject
sequenc
analysi
sangon
biotech
china
specif
bind
activ
pedv
n
protein
nanobodi
determin
indirect
elisa
specif
determin
accord
method
describ
tgev
n
protein
appli
control
bind
activ
assess
method
assay
posit
nanobodi
unrel
nanobodi
dilut
multipl
factor
order
verifi
affin
pedv
n
antigen
bind
nb
conduct
surfac
plasmon
reson
spr
analysi
use
biacor
instrument
ge
healthcar
life
scienc
usa
experiment
procedur
follow
purifi
pedv
n
protein
immobil
onto
flow
cell
sensor
chip
ge
healthcar
life
scienc
usa
use
standard
amineimmobil
kit
specifi
manufactur
biacor
spr
assay
perform
use
hbsep
run
buffer
mm
hepe
ph
mm
nacl
mm
edta
vv
surfact
biacor
instrument
room
temperatur
concentr
flow
chip
surfac
respect
chip
regener
buffer
ph
sensorgram
analyz
use
bia
evalu
softwar
version
nanobodi
sampl
exhibit
good
specif
bind
activ
affin
select
subsequ
experi
gene
encod
pedv
n
protein
specif
nanobodi
amplifi
primer
sangon
biotech
china
contain
bamhi
hindiii
site
avitag
addit
file
tabl
clone
express
vector
recombin
plasmid
transform
e
coli
express
nanobodi
cell
grown
lb
rmin
bacteri
cultur
reach
approxim
follow
express
induc
use
mm
iptg
follow
incub
rmin
h
cell
collect
centrifug
ultrason
treat
solubl
protein
suspend
pb
purifi
ninta
accord
manufactur
instruct
ge
healthcar
life
scienc
usa
purifi
solubl
protein
final
concentr
mgml
biotinyl
use
biotin
ligas
genecopoeia
china
accord
manufactur
instruct
specif
bionanobodi
test
indirect
elisa
six
differ
viral
protein
pedv
n
pedv
tgev
n
prrsv
n
pcv
cap
prv
ge
protein
chosen
test
potenti
crossreact
amount
six
protein
use
coat
plate
incub
overnight
block
biotinylatednanobodi
dilut
differ
concentr
incub
antigen
h
hrpconjug
streptavidin
dilut
mpb
ad
incub
min
anoth
wash
step
fresh
tmb
solut
prepar
describ
ad
plate
incub
min
reaction
stop
addit
absorb
nm
read
microtit
plate
reader
biotinyl
nanobodi
block
elisa
belisa
perform
amplifi
system
achiev
optim
block
elisa
perform
variou
experiment
condit
optim
first
checkboard
titrat
implement
indirect
elisa
determin
optim
concentr
antigen
ngwell
ngwell
ngwell
ngwell
dilut
factor
correspond
biotinyl
nanobodi
absorb
solut
antigenco
well
close
concentr
correspond
coat
antigen
dilut
factor
biotinyl
nanobodi
consid
optim
carri
belisa
plate
coat
optim
concentr
pedv
n
protein
incub
overnight
block
bsa
h
posit
neg
sera
serial
dilut
ad
well
differ
length
time
min
min
min
min
plate
wash
four
time
pb
afterward
biotinyl
nanobodi
ad
well
incub
differ
length
time
min
min
min
min
plate
wash
three
time
pbst
optim
concentr
hrpconjug
streptavidin
thermo
fisher
usa
ad
incub
optim
reaction
time
min
min
min
min
anoth
wash
step
fresh
tmb
solut
prepar
describ
ad
plate
incub
min
reaction
stop
addit
absorb
nm
read
microtit
plate
reader
percentag
inhibit
pi
pi
test
serum
refer
serum
highest
absorb
neg
serum
closest
experiment
condit
consid
optim
nineti
standard
pedvneg
serum
sampl
confirm
pedvneg
rtpcr
commerci
elisa
kit
use
defin
cutoff
valu
block
elisa
procedur
base
method
mention
two
threshold
cutoff
valu
defin
mean
pi
valu
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
overlin
x
end
document
neg
sampl
n
standard
deviat
sd
serum
sampl
show
pi
valu
greater
equal
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
overlin
x
end
document
consid
pedvseroposit
serum
sampl
show
pi
valu
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
overlin
x
end
document
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
overlin
x
end
document
consid
suspici
serum
sampl
show
pi
valu
less
equal
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
overlin
x
end
document
consid
pedvseroneg
specif
biotinyl
nanobodi
belisa
evalu
first
serum
posit
common
pig
pathogen
includ
tgev
ppv
prrsv
prv
jev
csfv
use
block
elisa
analysi
perform
accord
step
posit
serum
sampl
confirm
pedvneg
use
rtpcr
commerci
elisa
kit
five
differ
viral
protein
pedv
n
pedv
tgev
n
pcv
cap
prv
ge
protein
ngwell
use
coat
plate
overnight
belisa
perform
accord
step
evalu
sensit
belisa
standard
posit
neg
sera
dilut
differ
concentr
subject
belisa
repeat
belisa
evalu
four
pedvseroposit
sampl
two
pedvseroneg
determin
intraassay
variabl
determin
intraassay
variabl
sampl
test
time
differ
oper
differ
occas
result
present
standard
deviat
sd
percentag
inhibit
group
sampl
biotinyl
nanobodi
belisa
appli
evalu
field
serum
sampl
total
one
hundr
fifti
field
serum
sampl
unknown
pedv
exposur
statu
collect
farm
shannxi
shandong
provinc
sampl
analysi
belisa
describ
valid
result
biotinyl
nanobodi
belisa
pedv
exposur
statu
sampl
also
confirm
commerci
elisa
kit
accord
manufactur
instruct
statist
analysi
draw
perform
use
graphpad
prism
softwar
graphpad
softwar
inc
la
jolla
ca
usa
kappa
valu
calcul
estim
coincid
belisa
commerci
elisa
kit
use
spss
softwar
version
http
wwwspsscomcn
strategi
use
construct
vhh
librari
describ
fig
gener
vhhspecif
pedv
n
protein
healthi
male
bactrian
camel
immun
highli
pure
nhistag
recombin
protein
five
time
interv
polyclon
antisera
extract
day
fifth
immun
use
evalu
antin
protein
respons
indirect
elisa
viral
titer
antiserum
collect
follow
fifth
immun
reach
indic
antiserum
produc
rais
good
immunogen
respons
addit
file
fig
total
rna
extract
peripher
blood
lymphocyt
pbl
revers
transcrib
cdna
construct
vhh
librari
cdna
use
templat
amplifi
specif
vhh
fragment
use
nest
pcr
bp
fragment
first
pcr
product
addit
file
fig
bp
fragment
vhh
pcr
product
gener
use
first
purifi
product
templat
addit
file
fig
purifi
vhh
product
linear
pcantab
phagemid
vector
ligat
electropor
electrocompet
e
coli
cell
transform
cell
cultur
lb
agar
plate
gener
vhh
librari
size
librari
approxim
pfuml
evalu
calcul
number
coloni
gradient
dilut
ninetysix
singl
coloni
randomli
select
bacteri
fluid
pcr
eleven
singl
posit
coloni
randomli
select
sequenc
recombin
rate
librari
approxim
amino
acid
sequenc
homolog
approxim
indic
rich
divers
librari
addit
file
fig
titer
recombin
phage
librari
reach
pfuml
rescu
construct
librari
helper
phage
obtain
highli
specif
nanobodi
pedv
n
protein
three
consecut
round
biopan
carri
use
pedv
n
protein
pb
antigen
titer
recombin
phage
final
eluent
round
pan
test
evalu
enrich
specif
phage
compar
observ
neg
control
enrich
factor
higher
first
second
third
round
pan
respect
indic
significantli
enrich
specif
nanobodi
biopan
tabl
moreov
obtain
solubl
nanobodi
high
divers
affin
clone
randomli
select
round
screen
pedv
n
protein
periplasm
extract
follow
phage
elisa
divers
elisaposit
coloni
determin
sequenc
plasmid
extract
clone
exhibit
posit
reaction
compar
neg
control
fig
analyz
sequenc
accord
amino
acid
sequenc
three
highli
variabl
complementari
determin
region
clone
nanobodi
divid
three
group
fig
complementari
determin
region
contain
typic
hydrophil
amino
acid
substitut
framework
rel
conserv
includ
ge
substitut
posit
three
nanobodi
vf
lr
wg
substitut
posit
respect
addit
region
also
contain
cystein
residu
form
disulfid
bond
contribut
format
ring
structur
play
import
role
stabil
structur
antigenbind
region
nanobodi
explain
absenc
interact
vl
domain
well
high
solubl
vhh
singledomain
fragment
evalu
specif
bind
activ
affin
three
nanobodi
pedv
n
tgev
n
protein
subject
peelisa
reveal
specif
bind
pedv
n
protein
without
crossreact
tgev
n
protein
addit
file
fig
titer
three
nanobodi
unrel
nanobodi
also
determin
assess
bind
activ
indic
higher
bind
activ
addit
file
fig
sensorgram
indic
pedv
n
protein
interact
respect
addit
file
fig
furthermor
use
langmuir
model
sensorgram
data
kinet
analysi
pedv
n
protein
nb
ka
valu
indic
fast
associ
constant
respect
pedv
n
protein
addit
file
tabl
kakd
valu
equilibrium
dissoci
constant
pedv
n
protein
measur
reach
respect
addit
file
tabl
overal
data
suggest
exhibit
highest
bind
affin
pedv
n
protein
therefor
select
appli
studi
properti
nanobodi
includ
small
size
approxim
kda
high
affin
high
level
stabil
singlestrand
composit
nanobodi
easi
produc
microorgan
higher
level
tradit
antibodi
produc
protein
gene
clone
express
vector
recombin
vector
transform
cell
recombin
protein
kda
express
inclus
bodi
detect
sdspage
fig
highli
pure
protein
obtain
purif
use
affin
column
puriti
detect
sdspage
fig
protein
renatur
pb
continu
dialysi
biotinyl
form
produc
use
biotin
ligas
vitro
name
ensur
specif
pedv
n
protein
reaction
pedv
n
pedv
tgev
n
prrsv
n
pcv
cap
prv
ge
protein
examin
indirect
elisa
dilut
bound
pedv
n
protein
high
specif
moreov
even
high
concentr
exhibit
crossreact
viral
protein
fig
checkboard
titrat
method
first
carri
indirect
elisa
determin
optim
concentr
pedv
n
protein
ngwell
dilut
factor
correspond
antibodi
furthermor
variou
experiment
condit
optim
accord
belisa
procedur
plate
coat
ngwell
pedv
n
protein
incub
overnight
addit
file
fig
next
day
well
block
ba
h
posit
neg
sera
dilut
ad
well
follow
incub
h
addit
file
plate
wash
three
time
pbst
afterward
biotinyl
nanobodi
dilut
ad
well
incub
min
addit
file
fig
plate
wash
three
time
pbst
hrpconjug
streptavidin
dilut
ad
plat
incub
h
addit
file
anoth
wash
step
fresh
tmb
solut
prepar
describ
ad
plate
incub
min
reaction
stop
addit
absorb
nm
read
microtit
plate
reader
use
calcul
block
rate
determin
cutoff
valu
belisa
one
hundr
standard
pedvneg
serum
sampl
test
belisa
averag
pi
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
overlin
x
end
document
neg
serum
sampl
standard
deviat
sd
block
rate
determin
sampl
thu
cutoff
valu
belisa
indic
sampl
pi
consid
pedvseroposit
sampl
pi
consid
suspici
sampl
pi
consid
pedvseroneg
serum
posit
differ
pathogen
often
clinic
observ
use
evalu
specif
block
elisa
pedvseroposit
serum
block
bind
antigen
serum
seroposit
pathogen
fig
addit
among
well
coat
five
differ
viral
protein
coat
pedv
n
protein
bound
pedv
posit
serum
effect
block
bind
although
viral
protein
exhibit
higher
block
rate
neither
pedv
serum
react
protein
addit
file
fig
result
suggest
establish
belisa
exhibit
high
specif
analys
sensit
belisa
establish
belisa
use
analyz
pedvseroposit
sera
differ
concentr
shown
fig
serum
dilut
factor
reach
result
consid
suspici
result
reveal
block
elisa
detect
pedvseroposit
serum
highest
dilut
factor
indic
high
level
belisa
sensit
determin
repeat
block
elisa
intraassay
variabl
determin
test
four
replic
four
posit
serum
two
neg
serum
sampl
belisa
display
good
repeat
determin
four
posit
two
neg
serum
test
differ
occas
differ
oper
fig
assess
whether
develop
belisa
use
clinic
sampl
one
hundr
fifti
field
serum
sampl
detect
develop
block
elisa
result
compar
commerci
elisa
kit
nineteen
sampl
judg
pedvseroposit
accord
develop
block
elisa
sampl
pedvseroneg
sampl
consid
suspici
howev
sampl
determin
pedvseroposit
commerci
elisa
kit
sampl
pedvseroneg
coincid
rate
two
method
tabl
addit
statist
analysi
show
result
belisa
highli
consist
commerci
elisa
kit
kappa
result
develop
block
elisa
highli
correl
commerci
elisa
kit
block
elisa
sensit
base
good
sensit
specif
observ
develop
belisa
use
belisa
advantag
commerci
kit
market
furthermor
pedv
nanobodi
use
sensit
specif
method
highthroughput
promis
diagnost
test
detect
pedv
antiserum
farm
pig
compar
monoclon
antibodi
polyclon
antibodi
use
current
elisa
prepar
nanobodi
simpler
inexpens
furthermor
belisa
save
time
least
hour
faster
compar
elisa
kit
market
therefor
belisa
like
wide
use
futur
past
decad
frequent
outbreak
ped
caus
highli
virul
pedv
strain
occur
mani
swine
rais
countri
includ
asia
europ
caus
substanti
financi
loss
therefor
rapid
accur
diagnost
method
necessari
conduct
epidemiolog
studi
perform
immun
efficaci
studi
pedv
n
protein
best
candid
antigen
earli
diagnosi
sinc
highli
conserv
pig
produc
high
level
antibodi
n
protein
earli
stage
pedv
infect
serolog
studi
valuabl
tool
investig
preval
diffus
pedv
date
mani
differ
type
elisa
method
develop
method
base
use
expens
convent
antibodi
includ
polyclon
monoclon
antibodi
character
complex
product
process
exhibit
low
yield
costli
therefor
use
nanobodi
variabl
domain
heavi
chainonli
antibodi
first
discov
camelid
shark
nanobodi
express
larg
quantiti
use
prokaryot
express
system
present
studi
describ
first
time
success
develop
valid
nbbase
pedv
n
protein
block
elisa
detect
antibodi
pig
serum
specif
nanobodi
pedv
n
protein
specif
bind
n
protein
high
bind
activ
gener
dromedari
immun
vhh
librari
use
phage
display
techniqu
notabl
specif
sensit
elisa
also
determin
antibodi
probe
current
two
commonli
use
antibodyprob
elisa
horseradish
peroxidas
hpr
biotin
strong
affin
biotin
streptavidin
sa
one
sa
molecul
specif
bind
four
molecul
biotin
addit
biotinsa
complex
resist
harsh
environment
element
proteolyt
enzym
organ
solvent
extrem
temperatur
ph
favor
properti
biotinsa
system
use
extens
diagnost
therapeut
function
therefor
biotinyl
purifi
nanobodi
fuse
avitag
use
biotin
ligas
vitro
establish
new
bionbbas
block
elisa
detect
antibodi
pedv
newli
develop
block
elisa
evalu
term
specif
sensit
crossreact
exhibit
excel
specif
sensit
crossreact
serum
posit
tgev
ppv
prrsv
prv
jev
csfv
intraassay
comparison
also
reveal
good
repeat
method
addit
newli
develop
block
elisa
compar
commerci
porcin
epidem
diarrhea
viru
antibodi
test
kit
total
serum
sampl
collect
herd
sever
pig
farm
shannxi
shandong
provinc
coincid
rate
two
method
tabl
indic
high
correl
develop
block
elisa
tradit
elisa
studi
success
construct
rich
divers
immun
phage
display
librari
three
strain
specif
nanobodi
pedv
n
protein
isol
three
consecut
round
biopan
use
phage
display
technolog
among
nanobodi
show
good
specif
bind
activ
furthermor
novel
rapid
specif
lowcost
block
elisa
develop
base
biotinyl
appli
assess
clinic
serum
sampl
first
report
case
nanobodi
pedv
practic
applic
therefor
belisa
may
becom
promis
diagnost
kit
detect
pedv
antiserum
pig
farm
